NOSO-COR Project - Multicenter study on nosocomial transmission of SARS-CoV2 virus

Head :
Philippe VANHEMS , Laboratoire des Pathogènes Emergents, Fondation Mérieux, / Service Hygiène, Epidémiologie et Prévention

Last update : 09/22/2021 | Version : 1 | ID : 73991

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

French version
send
Send
General
Identification
Detailed name Multicenter study on nosocomial transmission of SARS-CoV2 virus
Sign or acronym NOSO-COR Project
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation 2020-A00546-33
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Pathology (details) COVID-19
Health determinants Medicine
Keywords Covid-19, nosocomial infections
Scientific investigator(s) (Contact)
Name of the director Philippe
Surname VANHEMS
Address Laboratoire des Pathogènes Emergents, Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS, UMR5308, ENS de Lyon, UCBL1, Lyon, France
And,
Centre Hospitalier Hôpital Edouard Herriot – Hospices Civils de Lyon
Service Hygiène, Epidémiologie et Prévention
5 Place d'Arsonval, 69003 Lyon, France
Phone +33 472 110 720
Email philippe.vanhems@chu-lyon.fr
Unit Laboratoire des Pathogènes Emergents, Fondation Mérieux, / Service Hygiène, Epidémiologie et Prévention
Organization Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS, UMR5308, ENS de Lyon, UCBL1, Lyon, France / Centre Hospitalier Hôpital Edouard Herriot – Hospices Civils de Lyon
Collaborations
Participation in projects, networks and consortia Yes
Details Fondation Mérieux-Réseau GABRIEL, I-MOVE-COVID-19
Funding
Details Bill & Melinda Gates Foundation-BMGF, Reacting INSERM
Governance of the database
Sponsor(s) or organisation(s) responsible Hospices Civils de Lyon
Organisation status Public
Presence of scientific or steering committees No
Additional contact
Address
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is is made on the basis of: Another treatment or procedure
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. This study focused on volunteers, patients and HCPs within the participant hospitals associated with the GABRIEL network (https://www.gabriel-network.org/) and French university hospitals. Other hospitals were integrated with this project on a voluntary basis.

Database objective
Main objective Describe and document suspected or confirmed cases of SARS-CoV2 nosocomial infections, their clinical spectrum and the determinants (risk factors / protection) at the participating hospitals.
Inclusion criteria Any voluntary adult or child or any healthcare workers from the study participant hospital who presents an infectious syndrome including the following definitions and oral/written informed consent obtained from parent/guardian for children < 18-years-old. (upon ethical requirements at each participant site).

Definitions
Suspect Case:
- Fever above 37.8 ° C if no antipyretics are taken; And or
- Cough or pharyngeal pain or other symptom suggestive of respiratory infection.
AND at least 1 of the following characteristics:
- return from a trip to China, or to a country in which the increase in the incidence of infections in SARS-CoV2 has been proven;
- close contact (sharing the same place of family, professional life, same plane, etc.) with a person defined as a suspected or confirmed case;
- Occurring in a hospital having received at least one suspected or confirmed case of SARS-CoV2 infection.


Confirmed Case
- The same clinical definitions, in addition to a positive RT-PCR-type virological diagnostic result specific to SARS-CoV2.
Population type
Age Infant (28 days to 2 years)
Early childhood (2 to 5 years)
Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology I - Certain infectious and parasitic diseases
Gender Male
Woman
Geography area International
Detail of the geography area France, Madagascar, Cote D'Ivoire, Mali, Guinea, Bangladesh, Lebanon
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Date of last collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 3221
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Clinical data (detail) Medical registration
Details of collected clinical data Symptoms, admission in ICU, ventilation, complications, length of stay
Declarative data (detail) Phone interview
Details of collected declarative data phone interview for healthcare professional only
Paraclinical data (detail) demographic data, hygiene measures
Biological data (detail) virological test, complete blood count, biochemical parameters
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Health care consumption and services
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Medicines consumption
Procedures
Data collection method In this prospective study, data were from patient's medical file. Healthcare professionnal were contacted by phone to anwer the questions.
Participant monitoring Yes
Monitoring procedures Monitoring by crossing with a medical-administrative database
Details on monitoring of participants Patient were follwing until the end of their hospitalization to have informations about complications after event.
Links to administrative sources No
Promotion and access
Promotion
Link to the document https://bmjopen.bmj.com/content/10/10/e039088.long
Description Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV2 transmission
Link to the document https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0243709
Description Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France
Link to the document https://onlinelibrary.wiley.com/doi/10.1002/jmv.27233
Description Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France
Access
Presence of document that lists variables and coding procedures Yes
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05